文献速递外周动脉疾病

膝下动脉斑块旋切联合球囊扩张与单纯球囊扩张治疗严重肢体缺血的当代结局

Contemporary outcomes of infrapopliteal atherectomy with angioplasty versus balloon angioplasty alone for critical limb ischemia.
PubMed 文献 · J Vasc Surg · 2019-11-11

本回顾性单中心纵向研究比较了膝下动脉斑块旋切联合球囊扩张与单纯球囊扩张治疗严重肢体缺血的效果,共纳入342次介入(290例患者)。两组一期通畅率相似,但联合组再干预率和局部并发症率更高。

要点

  • 膝下动脉斑块旋切联合球囊扩张与单纯球囊扩张的一期通畅率相似。
  • 联合组再干预率显著高于单纯球囊扩张组。
  • 联合组局部并发症率较高。

核心结论

  • 膝下动脉斑块旋切联合球囊扩张治疗严重肢体缺血的一期通畅率与单纯球囊扩张相似,但再干预率和局部并发症率更高。

研究设计与样本

  • 共342次介入(290例患者),其中单纯球囊扩张183次(54%),斑块旋切联合球囊扩张159次(46%)。
  • 患者平均年龄67±12岁,男性占61%。

临床怎么用

  • 对于严重肢体缺血的膝下动脉病变,斑块旋切联合球囊扩张可作为单纯球囊扩张的替代选择,但需注意更高的再干预率和局部并发症风险。

局限性

  • 回顾性单中心研究设计。
  • 需要进一步设计良好的研究来确定斑块旋切在该类患者中的确切作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Limited data exist comparing atherectomy (At) with balloon angioplasty for infrapopliteal peripheral arterial disease. The objective of this study was to compare the outcomes of infrapopliteal At with angioplasty vs angioplasty alone in patients with critical limb ischemia. METHODS: This is a retrospective, single-center, longitudinal study comparing patients undergoing either infrapopliteal At with angioplasty or angioplasty alone for critical limb ischemia, between January 2014 and October 2017. The primary outcome was primary patency rates. Secondary outcomes were reintervention rates, assisted primary patency, secondary patency, major adverse cardiac events, major adverse limb events, amputation-free survival, overall survival, and wound healing rates. Data were analyzed in multivariate generalized linear models with log rank tests to determine survival in Kaplan-Meier curves. RESULTS: There were 342 infrapopliteal interventions, 183 percutaneous balloon angioplasty (PTA; 54%), and 159 atherectomies (At) with PTA (46%) performed on 290 patients, with a mean age of 67 ± 12 years; 61% of the patients were male. The PTA and At/PTA groups had similar demographics, tissue loss (79% vs 84%; P = .26), ischemic rest pain (21% vs 16%; P = .51), mean follow-up (19 ± 9 vs 20 ± 9 months; P = .32), mean number of vessels treated (1.7 ± 0.8 vs 1.9 ± 0.8; P = .08) and the mean lesion length treated (6.55 ± 5.00 cm vs 6.02 ± 4.00 cm; P = .08), respectively. Similar 3-month (96 ± 1% vs 94 ± 1%), 6-month (85 ± 2% vs 86 ± 3%), 12-month (68 ± 3% vs 69 ± 4%), and 18-month (57 ± 4% vs 62 ± 4%) primary patency rates were seen in the two groups (P = .87). At/PTA patients had significantly higher reintervention rates as compared with the PTA patients (28% vs 16%; P = .02). Similar assisted primary patency rates (67 ± 4% vs 69 ± 4%; P = .78) and secondary patency rates (61 ± 4% vs 66 ± 4%; P = .98) were seen in the PTA and At/PTA groups at 18 months. The 30-days major adverse cardiac event rates (3% vs 2%; P = .13) and 30-day major adverse limb event rates (5% vs 4%; P = .2) were similar in both groups. Wound healing rates (72 ± 3% vs 75 ± 2%; P = .12), 1-year amputation-free survival (68 ± 4.1% vs 70 ± 2%; P = .5), and 1-year overall survival (76 ± 4% vs 78 ± 4%; P = .39) rates did not differ in the PTA and At/PTA groups. THE At/PTA group had higher local complication rates (7 [4%] vs 1 [0.5%]; P = .03) CONCLUSIONS: At with angioplasty provides similar patency rates compared with angioplasty alone for infrapopliteal peripheral arterial disease, but associated with higher reintervention and local complication rates. Further appropriately designed studies are required to determine the exact role of At in this subset of patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zia S, Juneja A, Shams S, et al. Contemporary outcomes of infrapopliteal atherectomy with angioplasty versus balloon angioplasty alone for critical limb ischemia. J Vasc Surg. 2019. PMID: 31727459. doi:10.1016/j.jvs.2019.08.254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。